levodopa has been researched along with oxazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, K; Karasawa, T; Shimizu, M; Yoshida, K | 1 |
| Iwata, H; Katayama, T; Kato, M; Matsuoka, Y; Narita, H; Yamamura, M | 1 |
| Hirose, S; Kaneko, S; Okada, M; Yoshida, S; Zhu, G | 1 |
| Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N | 1 |
4 other study(ies) available for levodopa and oxazoles
| Article | Year |
|---|---|
Effects of 1,2-benzisoxazole-3-acetamidoxime on central monoamine neurons in the rat.
Topics: Animals; Biogenic Amines; Brain; Brain Chemistry; Isoxazoles; Levodopa; Male; Neurons; Oxazoles; Oximes; Psychotropic Drugs; Rats | 1976 |
In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Pressure; Levodopa; Male; Mice; Monoamine Oxidase Inhibitors; Naphthalenes; Oxazoles; Oxazolidinones; Rats; Rats, Wistar; Tyramine | 1998 |
Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca2+-induced Ca2+ releasing system in rat striatum.
Topics: Adenosine; Analysis of Variance; Animals; Calcium; Calcium Channels; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Electrochemistry; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Levodopa; Macrocyclic Compounds; Male; Microdialysis; Oxazoles; Potassium; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Ruthenium Red; Ryanodine; Ryanodine Receptor Calcium Release Channel; Time Factors; Verapamil | 2004 |
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine | 2004 |